Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $81,874 - $98,436
-1,300 Reduced 92.86%
100 $8,000
Q1 2018

Apr 26, 2018

SELL
$92.01 - $123.21 $27,603 - $36,963
-300 Reduced 17.65%
1,400 $133,000
Q4 2017

Feb 15, 2018

BUY
$89.56 - $98.21 $152,252 - $166,957
1,700
1,700 $164,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dumont & Blake Investment Advisors LLC Portfolio

Follow Dumont & Blake Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.